Guizhou Xinbang Pharmaceutical to pay 2025 semi-annual cash dividend

Guizhou Xinbang Pharmaceutical (SZSE:002390) announced the implementation of its 2025 semi-annual equity distribution, approved on September 17, 2025. The company will distribute a cash dividend of CNY 0.30 per 10 shares (including tax) to all shareholders. The total cash dividend amounts to CNY 56,892,189.84, based on a total share capital of 1,896,406,328 shares, after excluding 47,445,540 shares held in the company's dedicated buyback account, which are not eligible for this distribution.

The equity registration date for this distribution is September 25, 2025, with the ex-dividend date set for September 26, 2025. Cash dividends for A-share shareholders will be disbursed by China Securities Depository and Clearing Corporation Limited Shenzhen Branch and directly credited to their capital accounts on September 26, 2025. Specific individual A-share shareholders will have their cash dividends distributed directly by the company.

Differential tax rates will apply to dividends for Hong Kong market investors, overseas institutions, and individual holders of initial public offering (IPO) restricted shares and unrestricted tradable shares. The company will not withhold individual income tax upfront; instead, it will be calculated based on the holding period upon share transfer.